View:
Download DOC
Download PDF
Download XLS
SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Feeney John J.
(Last) (First) (Middle)
ONE TRIBOLOGY CENTER
102 WILLENBROCK ROAD
(Street)
OXFORD CT 06478
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
RBC Bearings INC [ RBC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Vice President and Secretary
3. Date of Earliest Transaction (Month/Day/Year)
12/15/2023
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Rule 10b5-1(c) Transaction Indication

  
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/15/2023 F 19(1) D $275.66 2,737(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option to Purchase Common Stock $135.53 12/15/2019 12/15/2025 Common Stock 40 40 D
Option to Purchase Common Stock $181.58 02/08/2024(3) 02/08/2028 Common Stock 168 168 D
Option to Purchase Common Stock $199.16 06/03/2022(4) 06/03/2028 Common Stock 2,000 2,000 D
Option to Purchase Common Stock $199.1 06/03/2023(5) 06/03/2029 Common Stock 2,000 2,000 D
Option to Purchase common Stock $199.51 06/01/2024(6) 06/01/2030 Common Stock 1,000 1,000 D
Explanation of Responses:
1. Represents shares withheld by the Company to pay tax liability related to the vesting of restricted stock.
2. Includes 1,870 shares of restricted stock, which vest according to the following schedule; 270 shares 1/3 of which vest on 2/8/2024, 1/3 vest on 2/8/2025 and 1/3 vest on 2/8/2026; 300 shares 1/3 of which vest on 6/3/2024, 1/3 vest on 6/3/2025 and 1/3 vest on 6/3/2026; 800 shares 1/4 of which vest on 6/3/2024, 1/4 vest on 6/3/2025, 1/4 vest on 6/3/2026 and 1/4 vest on 6/3/2027; and 500 shares 1/5 of which vest on 6/1/2024, 1/5 vest on 6/1/2025, 1/5 vest on 6/1/2026, 1/5 vest on 6/1/2027 and 1/5 vest on 6/1/2028.
3. These options to purchase Common Stock are subject to the following vesting schedule - 1/3 vest on 2/8/2024, 1/3 vest on 2/8/2025 and 1/3 vest on 2/8/2026.
4. All these options to purchase Common Stock are exerciseable except for 1,200 options that are subject to the following vesting schedule - 1/3 vest on 6/3/2024, 1/3 vest on 6/3/2025 and 1/3 vest on 6/3/2026.
5. All these options to purchase Common Stock are exerciseable except for 1,600 options that are subject to the following vesting schedule - 1/4 vest on 6/3/2024, 1/5 vest on 6/3/2025, 1/5 vest on 6/3/2026 and 1/4 vest on 6/3/2027.
6. These options to purchase Common Stock are subject to the following vesting schedule - 1/5 vest on 6/1/2024, 1/5 vest on 6/1/2025, 1/5 vest on 6/1/2026, 1/5 vest on 6/1/2027 and 1/5 vest on 6/1/2028.
Remarks:
/s/John J. Feeney 12/18/2023
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.